Screener
Pacific Biosciences of California PACB Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001299130-26-000122
| (In thousands, except par value) | June 30,2026 | December 31,2025 |
|---|---|---|
| Inventory, net | 61,084 | 49,285 |
| Prepaid expenses and other current assets | 9,545 | 10,793 |
| Short-term restricted cash | 33 | 20 |
| Total current assets | 338,639 | 375,052 |
| Property and equipment, net | 26,972 | 24,146 |
| Operating lease right-of-use assets, net | 40,331 | 41,695 |
| Long-term restricted cash | 1,571 | 1,532 |
| Intangible assets, net | 13,084 | 15,124 |
Item 1. Financial Statements (unaudited):
FAQ
- What is Pacific Biosciences of California's total current assets?
- Pacific Biosciences of California (PACB) reported total current assets of $338.64M in Q2 2026.
- How has Pacific Biosciences of California's total current assets changed year-over-year?
- Pacific Biosciences of California's total current assets decreased by 18.1% year-over-year, from $413.4M to $338.64M.
- What is the long-term trend for Pacific Biosciences of California's total current assets?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's total current assets has grown at a 1.1% compound annual growth rate (CAGR), from $355.59M to $375.05M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Pacific Biosciences of California's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude